Capital Fund Management (CFM)’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.82M Buy
+17,210
New +$4.52M 0.02% 935
2026
Q1
– Sell
-37,579
Closed -$9.43M – 2343
2025
Q4
$9.43M Buy
37,579
+19,437
+107% +$5.16M 0.03% 868
2025
Q3
$5.21M Buy
+18,142
New +$4.86M 0.01% 1224
2020
Q1
– Sell
-3,198
Closed -$465K – 1822
2019
Q4
$465K Buy
+3,198
New +$462K ﹤0.01% 1421
2019
Q1
– Sell
-23,069
Closed -$2.84M – 1906
2018
Q4
$2.5M Buy
+23,069
New +$3.09M 0.02% 761
2018
Q2
– Sell
-92,128
Closed -$13.9M – 2150
2018
Q1
$12.8M Buy
92,128
+82,286
+836% +$12.1M 0.08% 365
2017
Q4
$1.35M Buy
9,842
+415
+4% +$54.8K 0.01% 1108
2017
Q3
$1.22M Buy
+9,427
New +$1.26M 0.01% 898
2014
Q3
– Sell
-17,188
Closed -$1.51M – 1681
2014
Q2
$1.51M Sell
17,188
-20,144
-54% -$1.74M 0.02% 818
2014
Q1
$3.15M Buy
+37,332
New +$2.98M 0.04% 509

Other funds holding LH

Capital Fund Management (CFM)'s LH Position: Q2 2026 in Review

Capital Fund Management (CFM) opened a new position in Labcorp (LH) in Q2 2026: 17,210 shares worth $4.82M. The stake represents 0.02% of the portfolio and ranks #935 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in LH as recently as Q4 2025.

Capital Fund Management (CFM) first reported a position in LH in Q1 2014 and has held it in 10 quarters since. The position peaked at $12.8M in Q1 2018. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Capital Fund Management (CFM) held 17,210 shares of Labcorp worth $4.82M as of Q2 2026.
  • Labcorp was a new Capital Fund Management (CFM) position in Q2 2026.
  • Labcorp made up 0.02% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #935 holding.
  • Capital Fund Management (CFM) first reported a position in Labcorp in Q1 2014 and has held it in 10 quarters since.
  • Capital Fund Management (CFM)'s Labcorp position peaked at $12.8M in Q1 2018.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.